4 | SEC Filings Hub

Filing metadata

Accession number: 0001104659-22-063391
Form type: Form 4
Filer: RVL Pharmaceuticals plc
CIK: CIK 1739426
Filed: May 20, 2022
Reporting period: May 18, 2022
Description: Insider transaction

Documents

0001104659-22-063391-index.htm

Complete submission

0001104659-22-063391.txt

directory listing

Filed by

RVL Pharmaceuticals plc